GlassScriptPhysician profile
Gregory U Opara
NPI 1982193447
$2,073.79
in general payments reported to CMS, 2019-2025
25 companies · $602 in 2025
The $602 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $374 · 2023: $582 · 2024: $516 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $199.20 | 2023-2025 | Myfembree |
| Medtronic, INC. | $182.19 | 2022-2025 | Ligasure, Truclear |
| Hologic Sales and Service, LLC | $171.51 | 2023-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $156.65 | 2022-2025 | Slynd |
| Gynesonics, INC. | $154.08 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $143.52 | 2022-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $129.64 | 2022-2025 | |
| Evofem Biosciences, INC. | $104.32 | 2023-2025 | Phexxi, Solosec, Phexx |
| Baxter Healthcare | $104.06 | 2022-2025 | Perclot |
| Exact Sciences Corporation | $78.44 | 2023-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $72.89 | 2023 | Accrufer |
| Ethicon US, LLC | $71.87 | 2023-2024 | N/A |
| Sage Therapeutics, LLC | $66.25 | 2025 | Zurzuvae |
| Abbvie INC. | $65.28 | 2023-2025 | |
| Smith+Nephew, INC. | $57.70 | 2022-2023 | Pico 7 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $49.21 | 2024-2025 | |
| Agile Therapeutics, INC. | $46.21 | 2022-2023 | Twirla |
| Organon LLC | $43.70 | 2022-2024 | |
| Millicent US INC | $41.61 | 2024 | Intrarosa, Femring |
| Davol INC. | $35.28 | 2023 | Arista Ah Flexitip |
| Supernus Pharmaceuticals, INC. | $24.32 | 2025 | Qelbree |
| Urgo Medical North America, LLC | $20.87 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Genmab U.S., INC. | $20.73 | 2024 | Tivdak |
| Optumhealth Care Solutions, LLC | $17.21 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Dexcom, INC. | $17.05 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Opara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.